Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00332943
Status:
COMPLETED
Last Update Posted:
2007-09-20
First Post:
2006-06-01
Brief Title:
MR Colonography With Fecal Tagging Barium vs BariumFerumoxsil
Sponsor:
Herlev Hospital
Organization:
Herlev Hospital
Study Overview
Official Title:
MR Colonography With Fecal Tagging Barium vs BariumFerumoxsil
Status:
COMPLETED
Status Verified Date:
2007-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether Barium or BariumFerumoxsil is better for fecal tagging in MR colonography Patients referred to colonoscopy are offered MR colonography before colonoscopy Two days before colonography patients ingest either a contrast agent A 200 ml Barium sulphate solution 1gml four times a day or a 200 ml contrast agent B Barium sulfate25 and Ferumoxil75 four times a day which will render fecal masses invisible on the following MR colonography The patients are randomised to either contrast agent A or B The examinations are evaluated by two independent blinded readers who will rate the tagging quality of the contrast agents The quality of tagging will be rated by a Visual Analog Scale VAS and Relative contrast ReCon Iwall - Ilumen Iwall Ilumen
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| KA-20060039 | None | None | None |